Particulars |
|
|
|
Company Name
| Piramal Pharma Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
1,325.75 |
B.V. (₹) |
52.90 |
Sales(₹ Cr.) |
4,390.11 |
NP (₹ Cr.) |
387.88 |
NP Var% |
434.00 |
Div% |
1.00 |
CPS(₹) |
4.50 |
EPS (₹) |
2.90 |
Traded Value(₹ Lakhs) |
190.79 |
52 Week High |
308.00 |
52 Week Low |
114.00 |
Price BSE |
227.00 |
Price NSE |
227.00 |
Market Capital (₹ Cr.) |
30,101.11 |
P/C Ratio |
50.70 |
P/E Ratio |
77.60 |
Price Vs.BV |
4.29 |
|
Latest Quarter |
Year End |
202412 |
Sales (₹ Cr.) |
1,248.32 |
NP(₹ Cr.) |
118.80 |
NP Var % |
60.00 |
Trailing Twelve Months |
Year End |
202412 |
Sales |
5,121.21 |
OPM |
19.79 |
NP |
687.21 |
NP Var% |
329.94 |
EPS |
5.18 |
PE |
43.83 |
|
|